Prediction of posttraumatic stress and depression one-month post-injury: A comparison of two screening instruments.

Prediction of posttraumatic stress and depression one-month post-injury: A comparison of two screening instruments.
复制标题

DOI:
10.1037/hea0001114
复制
发表时间:
2021-10
期刊:
影响因子:
4.2
通讯作者:
Ruggiero, Kenneth
Ruggiero, Kenneth
中科院分区:
心理学2区
文献类型:
--
作者:
Ennis, Naomi;Anton, Margaret;Bravoco, Olivia;Ridings, Leigh;Hunt, Josh;deRoon-Cassini, Tern A.;Davidson, Tatiana;Ruggiero, Kenneth

文献摘要

参考文献

相似文献

探讨2种筛查工具在预测创伤后1个月抑郁和PTSD中的联合和个体效用。对484名I级创伤中心患者进行了围创伤窘迫量表(PDI)和创伤幸存者筛查(ITSS)。受伤后约30天,患者完成了DSM-5(PCL-5)和患者健康问卷(PHQ-8)的创伤后应激障碍检查表。PDI的受试者工作特征曲线(ROC)表明,预测PTSD(敏感性= 70%;特异性= 62%)和抑郁症(敏感性= 74%;特异性= 64%)的临界值为17.5。对于ITSS,ROC曲线表明1.5分的临界值预测PTSD(敏感性= 72%;特异性= 60%)和抑郁症(敏感性= 67%;特异性= 62%)。在回归分析中纳入这两种工具比单独预测PCL-5和PHQ-8评分的1项测量的方差大2.4%-6.8%。ITSS和PDI在实践中均表现出显著的临床实用性。与单独使用任何一种方法相比,使用这两种方法可能不会产生足够的额外临床获益。建议将随访筛查和/或持续症状监测作为简短床旁筛查的辅助措施。
To examine the combined and individual utility of 2 screening tools in prediction of depression and PTSD one-month post traumatic injury. 484 Level I Trauma Center patients were administered the Peritraumatic Distress Inventory (PDI) and Injured Trauma Survivor Screen (ITSS). Approximately 30 days post-injury, patients completed the Posttraumatic Stress Disorder Checklist for DSM–5 (PCL-5) and Patient Health Questionnaire (PHQ-8). Receiver operating characteristic curve (ROC) curves for the PDI suggested a cutoff score of 17.5 predicting PTSD (Sensitivity = 70%; Specificity = 62%) and depression (Sensitivity = 74%; Specificity = 64%). For the ITSS, ROC curves suggested a cutoff score of 1.5 to predict PTSD (Sensitivity = 72%; Specificity = 60%) and depression (Sensitivity = 67%; Specificity = 62%). Inclusion of both instruments in regression analyses accounted for 2.4%-6.8% greater variance than 1 measure alone in predicting PCL-5 and PHQ-8 scores. The ITSS and PDI each demonstrated significant clinical utility in practice. Use of both measures, versus either alone, likely does not produce sufficient added clinical benefit. Follow-up screening and/or ongoing symptom monitoring is recommended as an adjunct to brief bedside screening.
DOI: 10.1016/j.jamcollsurg.2020.03.037
发表时间: 2020-08-01
影响因子: 5.2
作者:
Ruggiero, Kenneth J.;Davidson, Tatiana M.;Fakhry, Samir M.
通讯作者: Fakhry, Samir M.
DOI: 10.1037/a0029256
发表时间: 2012-08-01
影响因子: 2.7
作者:
Bonanno, George A.;Kennedy, Paul;Elfstrom, Mangus L.
通讯作者: Elfstrom, Mangus L.
DOI: 10.1002/da.22873
发表时间: 2019-02-01
影响因子: 7.4
作者:
Geier, Timothy J.;Hunt, Joshua C.;deRoon-Cassini, Terri A.
通讯作者: deRoon-Cassini, Terri A.
DOI: 10.1176/appi.ajp.158.9.1480
发表时间: 2001-09-01
影响因子: 17.7
作者:
Brunet, A;Weiss, DS;Marmar, CR
通讯作者: Marmar, CR
DOI: 10.1080/20008198.2017.1353383
发表时间: 2017
影响因子: 5
作者:
Kessler RC;Aguilar-Gaxiola S;Alonso J;Benjet C;Bromet EJ;Cardoso G;Degenhardt L;de Girolamo G;Dinolova RV;Ferry F;Florescu S;Gureje O;Haro JM;Huang Y;Karam EG;Kawakami N;Lee S;Lepine JP;Levinson D;Navarro-Mateu F;Pennell BE;Piazza M;Posada-Villa J;Scott KM;Stein DJ;Ten Have M;Torres Y;Viana MC;Petukhova MV;Sampson NA;Zaslavsky AM;Koenen KC
通讯作者: Koenen KC